These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 16608626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R, Ares O, Sierra J, Pérez-Dominguez M.
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J, Miglinas M, Miltiniene D, Vajauskas D, Seinin D, Butenas P, Kacergius T.
    World J Surg Oncol; 2016 Jan 08; 14(1):4. PubMed ID: 26744291
    [Abstract] [Full Text] [Related]

  • 7. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
    Younis E, Jarrah N, Sroujieh AS, Al Hadidy A, Ajlouni K.
    Endocr Pract; 2001 Jan 08; 7(5):375-8. PubMed ID: 11585374
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ, Kwon SH, Kim SW, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2003 Jan 08; 60(3):127-33. PubMed ID: 12931040
    [Abstract] [Full Text] [Related]

  • 9. Tumor-induced osteomalacia: a case of diagnostic dilemma.
    Robertson A, Mansberg R, Mansberg V, Van der Wall H, Hooper M.
    Clin Nucl Med; 2007 Aug 08; 32(8):631-4. PubMed ID: 17667438
    [Abstract] [Full Text] [Related]

  • 10. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
    Fathalla H, Cusimano M, Di Ieva A, Karamchandani J, Fung R, Kovacs K.
    World Neurosurg; 2015 Jul 08; 84(1):189.e1-5. PubMed ID: 25746588
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S, Takeuchi Y, Nagano A, Fujita T.
    Bone; 1999 Sep 08; 25(3):375-7. PubMed ID: 10495143
    [Abstract] [Full Text] [Related]

  • 12. Severe hypophosphatemic osteomalacia with Fanconi syndrome, renal tubular acidosis, vitamin D deficiency and primary biliary cirrhosis.
    Bando H, Hashimoto N, Hirota Y, Sakaguchi K, Hisa I, Inoue Y, Imanishi Y, Seino S, Kaji H.
    Intern Med; 2009 Sep 08; 48(5):353-8. PubMed ID: 19252361
    [Abstract] [Full Text] [Related]

  • 13. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
    Takahashi M, Toru S, Ota K, Izumiyama H, Yokota T, Mizusawa H.
    Rinsho Shinkeigaku; 2008 Feb 08; 48(2):120-4. PubMed ID: 18326305
    [Abstract] [Full Text] [Related]

  • 14. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
    Miyauchi A, Fukase M, Tsutsumi M, Fujita T.
    J Clin Endocrinol Metab; 1988 Jul 08; 67(1):46-53. PubMed ID: 2837500
    [Abstract] [Full Text] [Related]

  • 15. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
    Sandhu FA, Martuza RL.
    J Neurooncol; 2000 Jul 08; 46(3):241-7. PubMed ID: 10902855
    [Abstract] [Full Text] [Related]

  • 16. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
    Mathis DA, Stehel EJ, Beshay JE, Mickey BE, Folpe AL, Raisanen J.
    J Neurosurg; 2013 Apr 08; 118(4):903-7. PubMed ID: 23350780
    [Abstract] [Full Text] [Related]

  • 17. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
    Takemia T, Sato K, Miyata M, Imaki T, Shibasaki T, Tsushima T, Demura H, Tanaka R, Obara T, Oguchi S.
    Endocr J; 1993 Feb 08; 40(1):121-6. PubMed ID: 7951485
    [Abstract] [Full Text] [Related]

  • 18. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG, Gitelis S, Charters JR.
    Calcif Tissue Int; 1986 Jun 08; 38(6):358-62. PubMed ID: 3089559
    [Abstract] [Full Text] [Related]

  • 19. A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.
    Yamaguchi S, Maruyama T, Wakino S, Tokuyama H, Hashiguchi A, Tada S, Homma K, Monkawa T, Thomas J, Miyashita K, Kurihara I, Yoshida T, Konishi K, Hayashi K, Hayashi M, Itoh H.
    BMC Nephrol; 2015 Nov 11; 16():187. PubMed ID: 26554665
    [Abstract] [Full Text] [Related]

  • 20. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL, Feig DS, Blackstein ME.
    J Endocrinol Invest; 2000 Apr 11; 23(4):263-7. PubMed ID: 10853715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.